Analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report released on Thursday. The brokerage set a “sell” rating on the basic materials company’s stock.
Arcadia Biosciences Stock Down 2.0 %
Shares of RKDA stock opened at $5.92 on Thursday. The business has a 50 day moving average of $4.54 and a two-hundred day moving average of $3.49. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The company has a market cap of $8.08 million, a P/E ratio of -1.38 and a beta of 1.19.
About Arcadia Biosciences
Read More
- Five stocks we like better than Arcadia Biosciences
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Work and Play: Investing in the Rise of Bleisure Travel
- 3 Tickers Leading a Meme Stock Revival
- Top Dividend Stocks to Buy Now as Bond Yields Could Lower
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- SAP: AI Tailwinds Accelerating Enterprise Cloud Business
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.